Atai Life Sciences Nv earnings were -$149.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ATAI earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$26.4M, down 32.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATAI reported annual earnings of -$149.3M, with 271.1% growth.
Atai Life Sciences Nv Earnings Reports & History FAQ
What were Atai Life Sciences Nv's earnings last quarter?
On ATAI's earnings call on Invalid Date, Atai Life Sciences Nv (NASDAQ: ATAI) reported Q1 2025 earnings per share (EPS) of -$0.15, up 11.76% year over year. Total ATAI earnings for the quarter were -$26.43 million. In the same quarter last year, Atai Life Sciences Nv's earnings per share (EPS) was -$0.17.
Is Atai Life Sciences Nv profitable or losing money?
As of the last Atai Life Sciences Nv earnings report, Atai Life Sciences Nv is currently losing money. Atai Life Sciences Nv's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$148.99 million, a 340.75% increase year over year.
What was ATAI's earnings growth in the past year?
As of Atai Life Sciences Nv's earnings date in Invalid Date, Atai Life Sciences Nv's earnings has grown year over year. ATAI earnings in the past year totalled -$148.99 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.